Original Article

Using Pill Identification Calls to Poison Centers as a Marker of Drug Abuse at Three Texas Military Bases

Authors: Patrick C. Ng, MD, Joseph K. Maddry, MD, Daniel Sessions, MD, Douglas J. Borys, PharmD, Vikhyat S. Bebarta, MD

Abstract

Objectives: Opioid abuse is a growing problem in civilian communities, and it has developed in the military as well. Telephone calls to poison centers requesting pill identification (ID) is a marker of drug abuse. This study identifies the number of pill ID calls made to the poison centers from areas containing and surrounding three Texas military bases during an 8-year period.

Methods: We performed a retrospective observational study identifying calls to certified poison centers in Texas from 2002 to 2009 that identified hydrocodone tablets and other pain medications. We noted the calls made from ZIP codes containing and surrounding the three largest military bases in Texas.

Results: We reviewed 75,537 drug ID calls for any drug from the ZIP codes of interest. Total drug ID calls increased 105% and the number of calls for hydrocodone increased 463%.

Conclusions: In our study most of the drug ID calls from military communities in Texas were for hydrocodone. The rate of calls for hydrocodone increased more than the rate of calls for other analgesics from 2002 to 2009. Using drug ID calls as a surrogate of drug abuse, our results suggest that hydrocodone abuse has increased within military communities and that poison center data can be a reliable surrogate for prescription drug abuse near military bases. Future studies are needed to further understand the extent of this problem in military and civilian communities. We can use this information to heighten awareness, influence prescription practices, establish practice guidelines, and develop educational programs to mitigate the increasing rate of prescription analgesic abuse in the United States.

 

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Substance Abuse and Mental Health National Survey on Drug Use and Health: Trends in Prevalence of Various Drugs for Ages 12 or Older, Ages 12 to 17, Ages 18 to 25, and Ages 26 or Older 2013-2015 (in percent). https://www.drugabuse.gov/national-survey-drug-use-health. Accessed September 6, 2017.
 
2. Murphy SL, Xu J, Kochanek KD, et al. Deaths: preliminary data for 2010. http://www.cdc.gov/nchs/data/nvsr/nvsr60/nvsr60_04.pdf. Accessed March 14, 2016.
 
3. Bray RM, Pemberton MR, Lane ME, et al. Substance use and mental health trends among U.S. military active duty personnel: key findings from the 2008 DoD Health Behavior Survey. Mil Med 2010;175:390-399.
 
4. Golub A, Bennett AS. Prescription opioid initiation, correlates, and consequences among a sample of OEF/OIF military personnel. Subst Use Misuse 2013;48:811-820.
 
5. Davis JM, Severtson SG, Bucher-Bartelson B, et al. Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits. Pharmacoepidemiol Drug Saf 2014;23:18-25.
 
6. Forrester MB. Drug identification calls from law enforcement received by Texas poison control centers, 2002-2004. J Toxicol Environ Health A 2006;69:2041-2049.
 
7. Law RK, Sheikh S, Bronstein A, et al. Incidents of potential public health significance identified using national surveillance of US poison center data (2008-2012). Clin Toxicol (Phila) 2014;52:958-963.
 
8. Jeffery DD, Babeu LA, Nelson LE, et al. Prescription drug misuse among U.S. active duty military personnel: a secondary analysis of the 2008 DoD survey of health related behaviors. Mil Med 2013;178:180-195.
 
9. Smith MY, Irish W, Wang J, et al. Detecting signals of opioid analgesic abuse: application of a spatial mixed effect poisson regression model using data from a network of poison control centers. Pharmacoepidemiol Drug Saf 2008;17:1050-1059.
 
10. Centers for Disease Control and Prevention. CDC guideline for prescribing opioids for chronic pain-United States, 2016. MMWR Morb Mortal Wkly Rep 2016;65:1-49.
 
11. Toblin RL, Quartana PJ, Riviere LA, et al. Chronic pain and opioid use in US soldiers after combat deployment. JAMA Intern Med 2014;174:1400-1401.
 
12. Platteborze PL, Kippenberger DJ, Martin TM. Unauthorized drug use in the US Army based on medial review officer evaluations. J Anal Toxicol 2014;38:653-659.
 
13. Miller M, Barber CW, Leatherman S, et al. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy. JAMA Intern Med 2015;175:608-615.
 
14. Larson MJ, Mohr BA, Jeffery DD, et al. Predictors of positive illicit drug tests after OEF/OIF deployment among Army enlisted service members. Mil Med 2016;181:334-342.
 
15. Spiller HA, Griffith JR. Increasing burden of pill identification requests to US Poison Centers. Clin Toxicol (Phila) 2009;47:253-255.
 
16. Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) System. http://www.radars.org/home2/overview. Accessed October 6, 2016.